A new scientific study on the treatment of breast cancer
A NEW SCIENTIFIC STUDY ON THE TREATMENT OF BREAST CANCER MADE BY THE SURGICAL-DIAGNOSTIC TEAM OF "M. C. AESCULAP" Recently, the medical scientific journal Frontiers in Oncology has published a scientific study by Prof. Dr. Nebojša Ivanović and co-authors, under the
Smart patients
The active participation of an informed patient in his treatment significantly improves the results of that treatment and increases the probability of a final cure Patients are the greatest underutilised potential of health care for improving treatment results and disease outcomes.
Disease stage, biological characteristics, and aggressiveness of breast cancer
- NOT ALL BREAST CANCERS ARE THE SAME - The prognosis of breast cancer and the final outcome of the disease depends on two major parameters: 1) disease stage 2) tumor biological characteristics. First, a few words about breast cancer course and prognosis. Breast
Core needle biopsy
The text contains relevant data and opinions about the core biopsy. However, we believe that for a patient with a suspicious breast finding, it is better to start the treatment with surgery without a core biopsy. Arguments for this position
Magnetic resonance in the diagnosis of breast diseases
Nuclear magnetic resonance (NMR) is a valuable diagnostic tool in breast diseases, provided it is used following the indications. The diagnostic advantage of magnetic resonance imaging over palpation, mammography and ultrasound is evident in cases of atypical cancer tissue presentation. For
Neoadjuvant chemotherapy for breast cancer
In some patients, breast cancer treatment begins with the use of drugs (cytostatics and biological therapies) instead of the usual practice of first performing surgery to remove the tumor and lymph nodes in the armpit and then administering the drugs. Administration
Genetic analyses of breast cancer (MAMMAPRINT)
Genetic testing for breast cancer is the most modern and reliable prognostic tool for cancer biological aggressiveness. Tests are performed on tumor tissue surgically removed from the body. One of the genetic tests for breast cancer available in Serbia is MammaPrint.